PMC5175043_01
Hemoglobin monitoring after lenalidomide use.
NCI-1-191-g001.jpg
PMC5175043_01_NCI-1-191-g001.jpg
F1
During further follow-up, increase in liver enzymes and severe thrombocytopenia were not detected; her hemoglobin value increased and transfusion dependency was not observed (Figure 1).